NewswireTODAY - /newswire/ - Männedorf, Switzerland, 2011/09/13 - The Tecan Group announced that it will present at the UBS Global Life Sciences Conference on Tuesday, September 20 in New York City. SIX Swiss Exchange: TECN

The Tecan Group today announced that it will present at the UBS Global Life Sciences Conference on Tuesday, September 20, 2011 in New York City.

The investor presentation will begin at 08:30 am. EDT (14:30 pm. CET) and will be webcast live. The webcast may be accessed under the “Investor Relations” tab of Tecan’s website tecan.com.

A replay of the webcast will be available shortly following the presentation and will remain available for at least four weeks.

About Tecan

Tecan (tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2010, Tecan generated sales of CHF 371 million (USD 356 million; EUR 269 million).

Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN: 12100191).

Agency / Source: Tecan Trading AG / Tecan Group Ltd

Availability: All Regions (Including Int'l)

Traffic Booster: [/] Quick NewswireToday Visibility Checker

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]